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Circadian Gene Clock Regulates Psoriasis-Like Skin
Inﬂammation in Mice
Noriko Ando1, Yuki Nakamura2, Rui Aoki1, Kayoko Ishimaru2, Hideoki Ogawa3, Ko Okumura3,
Shigenobu Shibata4, Shinji Shimada1 and Atsuhito Nakao2,3
There are several reports suggesting that the pathophysiology of psoriasis may be associated with aberrant
circadian rhythms. However, the mechanistic link between psoriasis and the circadian time-keeping system, “the
circadian clock,” remains unclear. This study determined whether the core circadian gene, Clock, had a
regulatory role in the development of psoriasis. For this purpose, we compared the development of psoriasis-like
skin inﬂammation induced by the Toll-like receptor 7 ligand imiquimod (IMQ) between wild-type mice and mice
with a loss-of-function mutation of Clock. We also compared the development of IMQ-induced dermatitis
between wild-type mice and mice with a loss-of-function mutation of Period2 (Per2), another key circadian gene
that inhibits CLOCK activity. We found that Clock mutation ameliorated IMQ-induced dermatitis, whereas the
Per2 mutation exaggerated IMQ-induced dermatitis, when compared with wild-type mice associated with
decreased or increased IL-23 receptor (IL-23R) expression in γ/δ+ T cells, respectively. In addition, CLOCK directly
bound to the promoter of IL-23R in γ/δ+ T cells, and IL-23R expression in the mouse skin was under circadian
control. These ﬁndings suggest that Clock is a novel regulator of psoriasis-like skin inﬂammation in mice via
direct modulation of IL-23R expression in γ/δ+ T cells, establishing a mechanistic link between psoriasis and the
circadian clock.
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INTRODUCTION
Psoriasis is a common chronic inﬂammatory skin disease
characterized by increased proliferation, altered differentia-
tion of the epidermis, and inﬁltration of inﬂammatory cells
such as neutrophils into the dermis (Lowes et al., 2014).
Recent studies suggest that IL-23 has a critical role in the
pathogenesis of psoriasis by inducing pathological T helper
type 17 (Th17) cells that release IL-17 and IL-22 (Kikly et al.,
2006; Fitch et al., 2007; Chiricozzi et al., 2014). However, it
is not fully understood how the IL-23 pathway in psoriasis is
regulated.
The circadian clock is an essential timing system driving
daily oscillations of behavior and physiology, such as sleep–
wake cycles and hormonal secretions (Dibner et al., 2010;
Mohawk et al., 2012). The mammalian circadian clock
system consists of the central oscillator, located in the supra-
chiasmatic nucleus of the hypothalamus, and peripheral
oscillators present in virtually all cell types including the skin
(Tanioka et al., 2009). The central suprachiasmatic nucleus
clock can receive light input from the retina that synchronizes
internal clock timing to the external solar day, which it passes
on to peripheral clocks via neural and endocrine path-
ways. The molecular mechanisms of rhythm generation are
highly conserved in the suprachiasmatic nucleus and
peripheral cells, and created and maintained by interlocked
transcriptional–translational feedback loops (Ukai and Ueda,
2010). The core loop is driven by two activators
(CLOCK and BMAL1) and two repressors (PERIOD (PER)
and CRYPTOCHROME (CRY)) (Dibner et al., 2010;
Mohawk et al., 2012). Brieﬂy, CLOCK and BMAL1
heterodimerize and activate transcription of the Per1/2 and
Cry1/2 genes, as well as other clock output genes, via the
E-box (or E-box-like) elements in the promoter region of the
genes. The PER and CRY proteins heterodimerize and, in turn,
suppress CLOCK/BMAL1 activity, thereby inhibiting their own
transcription.
There have been several reports suggesting that the
pathophysiology of psoriasis may be associated with aberrant
circadian rhythms (Gelfant et al., 1982; Mozzanica et al.,
1988; Bacaksiz et al., 2012). For instance, patients with
psoriasis had disrupted circadian rhythms in blood pressure
and heart rate (Bacaksiz et al., 2012). Furthermore, a
most recent study reported an increased risk of psoriasis in
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night-shift workers who had aberrant circadian rhythms
(Li et al., 2013). However, the mechanistic link between the
circadian clock and psoriasis remains unclear.
This study determined whether a core circadian gene,
Clock, had a regulatory role in the development of psoriasis.
For this purpose, we compared the development of psoriasis-
like dermatitis induced by the Toll-like receptor 7 ligand
imiquimod (IMQ) (van der Fits et al., 2009) between wild-type
mice and mice with a loss-of-function mutation of Clock
(ClockΔ19/Δ19 mice) (Vitaterna et al., 1994) or Period2 (Per2)
(mPer2m/m mice) (Zheng et al., 1999), another key circadian
protein that inhibits CLOCK activity.
RESULTS
Clock-mutated mice do not have obvious developmental defects
in the immune system
We ﬁrst checked whether ClockΔ19/Δ19 mice had any
developmental defects in the immune system. ClockΔ19/Δ19
mice showed normal numbers and percentages of CD4+,
CD8+ T cells, or B cells in the thymus and spleen (Supple-
mentary Figure S1a online). Serum IgG, IgA, and IgE levels,
fecal IgA levels, and peripheral blood white cell counts
and differentials were comparable between wild-type and
ClockΔ19/Δ19 mice (Supplementary Figure S1b online, data not
shown). ClockΔ19/Δ19 mice also showed comparable numbers
and percentages of γ/δ+ T cells in the spleen and skin with
wild-type mice (Supplementary Figure S1c online). These
results suggested that ClockΔ19/Δ19 mice did not have obvious
developmental defects in the immune system.
Clock mutation ameliorates IMQ-induced dermatitis
We treated wild-type and ClockΔ19/Δ19 mice daily with IMQ
cream or control cream at Zeitgeber time 2 (ZT2) (0800 hours)
on both ears and the shaved dorsal skin for 5 consecutive
days (days 1–5) as described previously (van der Fits et al.,
2009), and the severity of dermatitis was evaluated on day 6.
Upon IMQ treatment, ClockΔ19/Δ19 mice exhibited
signiﬁcantly lower levels of dermatitis compared with wild-
type mice, as judged by the Psoriasis Area Severity Index
(PASI) score in the dorsal skin, ear thickness, epidermal
hyperplasia, and frequency of CD3+ γ/δ+ T cells in the
cervical lymph nodes (Figure 1a and d). The inﬂamed skin
showed signiﬁcantly reduced expression of IL-22, S100A8,
and keratin 16 mRNAs in IMQ-treated ClockΔ19/Δ19 mice
when compared with wild-type mice on day 6, although
IL-17A and Reg3γ mRNA levels were comparable between
IMQ-treated wild-type mice and ClockΔ19/Δ19 mice
(Figure 1e). The number of inﬁltrating CD3+ T cells into the
skin decreased in IMQ-treated ClockΔ19/Δ19 mice compared
with IMQ-treated wild-type mice on day 6 (Supplementary
Figure S2 online). These results suggested that Clock mutation
ameliorated IMQ-induced skin inﬂammation in mice.
Clock mutation blunts γ/δ+ T cell responses to IL-23
A pivotal role of the IL-23/IL-17/IL-22 axis has been
demonstrated in the psoriasis-like skin inﬂammation induced
by IMQ in mice (van der Fits et al., 2009; Cai et al., 2011;
Pantelyushin et al., 2012; Van Belle et al., 2012; Wohn et al.,
2013; Yoshiki et al., 2014). Treatment of mice with IMQ is
thought to activate dermal dendritic cells or Langerhans cells,
releasing IL-23. IL-23, in turn, stimulated γ/δ+ T cells or Rorγt+
innate lymphoid cells (type 3 innate lymphoid cells (ILCs)) to
produce IL-17 and IL-22, thereby leading to recruitment of
neutrophils to the skin, keratinocyte proliferation, and release
of anti-microbial peptides (Flutter and Nestle, 2013).
We found that IL-23 p19 mRNA levels in the skin were
comparable between IMQ-treated wild-type and ClockΔ19/Δ19
mice on days 0, 2, and 6 (Figure 1e and Supplementary Figure
S3 online). In addition, the frequency of I-A/I-E+IL-23+ cells in
the cervical lymph nodes was comparable between IMQ-
treated wild-type and ClockΔ19/Δ19 mice on day 2 (Figure 1f).
We were unable to detect I-A/I-E+IL-23+ cells in the cervical
lymph nodes on day 6 (data not shown). These ﬁndings
suggested that production of IL-23, an innate cytokine that
was rapidly induced following topical IMQ treatment, was
comparable between wild-type and ClockΔ19/Δ19 mice.
Therefore, we hypothesized that Clock mutation affected
critical events downstream of IL-23 in the development of
IMQ-induced dermatitis.
We thus determined whether Clock mutation affected γ/δ+
T cell responses to IL-23. Interestingly, at basal conditions,
IL-23-induced IL-17A and IL-22 production signiﬁcantly
decreased in splenic γ/δ+ T cells isolated from ClockΔ19/Δ19
mice when compared with wild-type mice (Figure 2a).
Consistently, γ/δ+ IL-22+ or CD3+ IL-22+ cells decreased in
the cervical lymph nodes of IMQ-treated ClockΔ19/Δ19 mice
compared with those in IMQ-treated wild-type mice
(Figure 1d). Unexpectedly, the number of γ/δ+ IL-17A+ cells
or CD3+ IL-17A+ cells in the cervical lymph nodes was
comparable between IMQ-treated wild-type and ClockΔ19/Δ19
mice (Supplementary Figure S4 online).
Previously, Chan et al. (2006) reported that direct
intradermal administration of IL-23 into the skin induced
psoriasis-like skin inﬂammation in mice, which recapitulated
the dermatitis induced by IMQ treatment. Importantly, direct
treatment of ClockΔ19/Δ19 mice with mouse recombinant IL-23
also induced signiﬁcantly lower levels of dermatitis compared
with wild-type mice as judged by ear thickness and epidermal
hyperplasia in ClockΔ19/Δ19 mice (Figure 2b and c). These
results suggested that Clock mutation blunted γ/δ+ T cell
responses to IL-23 and resulted in reduced IMQ- or IL-23-
induced psoriasis-like skin inﬂammation in mice.
Clock regulates IL-23R expression in γ/δ T cells
To investigate the mechanisms behind blunted responses to
IL-23 in Clock-mutated γ/δ+ T cells, we examined the effects
of Clock mutation on IL-23 receptor (IL-23R) expression in
γ/δ+ T cells. IL-23R mRNA and protein expression levels
decreased in splenic γ/δ+ T cells from ClockΔ19/Δ19 mice
compared with wild-type mice (Figure 3a and b), suggesting
that CLOCK regulated IL-23R expression in γ/δ+ T cells.
Consistently, we noticed that several E-box-like elements that
CLOCK could bind to (Hardin, 2004) were present in the
promoter regions of the mouse IL-23R (Supplementary Figure
S5 online). As expected, chromatin immunoprecipitation
assay revealed that CLOCK bound to the promoter region of
N Ando et al.
Clock Regulates Psoriasis
3002 Journal of Investigative Dermatology (2015), Volume 135
IL-23R in wild-type splenic γ/δ+ T cells (Figure 3c). These
results suggested that CLOCK regulated the transcription of
IL-23R in γ/δ+ T cells in a direct manner. Collectively, Clock
mutation blunted γ/δ+ T cell responses to IL-23, at least in
part, by decreasing IL-23R expression and ameliorated IMQ-
induced dermatitis.
IL-23R expression shows circadian rhythms in the mouse skin
If IL-23R expression is regulated by CLOCK, IL-23R mRNA or
protein levels should show circadian variations. Indeed,
IL-23R mRNA levels exhibited circadian variations in the
wild-type, but not Clock-mutated, mouse skin (Figure 4a).
Expression of core clock genes such as Per2 and Bmal1 (Arntl)
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Figure 1. Clock mutation results in reduced imiquimod (IMQ)-induced skin inﬂammation. (a) Psoriasis Area Severity Index (PASI) score in the dorsal skin
(n= 10–12 per group). (b) Ear thickness (n= 10–12 per group). (c) Hematoxylin and eosin (HE) staining of the dorsal skin (n=5 per group). Bar=100 μm. (d)
Frequency of γ/δ+ T cells (CD3+γ/δ+ cells, IL-22+γ/δ+ cells, CD3+ IL-22+ cells) in the cervical lymph nodes evaluated by FACS analysis at Zeitgeber time 2 (ZT2)
(n= 7 per group). (e) IL-22, IL-17A, S100A8, Reg3γ, IL-23 p19, and keratin 16 mRNA expression at ZT2 in the inﬂamed skin evaluated by quantitative reverse
transcriptase in real time (qPCR) (n=3–5 per group). Ampliﬁcation was normalized to GAPDH. (f) Frequency of I-A/I-E+IL-23+ cells in the cervical lymph nodes
evaluated by FACS analysis at ZT2 (n= 3–4 per group). The values represent means± SD. *Po0.05.
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mRNA levels also showed circadian rhythms in the wild-type,
but not Clock-mutated, mouse skin (Figure 4a). The Clock
mRNA expression levels appeared to show circadian trend
both in the wild-type and Clock-mutated mouse skin, but
they were not statistically signiﬁcant (Figure 4a), which was
consistent with previous ﬁndings that Clock mRNA did not
show daily oscillations in the skin of healthy human subjects
(Bjarnason et al., 2001). These results suggested that IL-23R
expression was under circadian control in the mouse skin at
steady states. Of note, IL-23R mRNA expression levels were
comparable between wild-type mice and ClockΔ19/Δ19 mice
at ZT2 (0800 hours) (Supplementary Figure S3 online),
although IL-23R mRNA expression exhibited circadian varia-
tions. In addition, IL-23R mRNA expression levels in the skin
were comparable between wild-type mice and ClockΔ19/Δ19
mice on day 6 when the mice were sufﬁciently exposed to
IMQ and substantial inﬂammation occurred (Supplementary
Figure S3 online).
To determine whether the circadian variation of IL-23R
expression in the skin was translated to the susceptibility
to IMQ-induced dermatitis in mice, we treated mice with
IMQ either at ZT2 (0800 hours) or at ZT14 (1800 hours).
We found that mice treated with IMQ at ZT14 exhibited
more severe dermatitis than did mice treated with IMQ
at ZT2, as judged by ear thickness, epidermal thickness, and
frequency of γ/δ+ T cells in the cervical lymph nodes (Figure
4b–d). Collectively, these ﬁndings suggested that IMQ-
induced dermatitis exhibited a time-of-day-dependent varia-
tion in wild-type mice, possibly in association with circadian
IL-23R expression.
Per2 mutation exacerbates IMQ-induced dermatitis
As CLOCK and PER2 function in opposite directions as
integral clock proteins (i.e., CLOCK or PER2 acts as a positive
or negative limb of the circadian clock machinery, respec-
tively), it is possible that mice with a loss-of-function mutation
of Per2 exhibit opposite phenotypes to mice with a loss-of-
function mutation of Clock upon IMQ treatment.
As expected, mice with a loss-of-function mutation of Per2
(mPer2m/m mice) (Zheng et al., 1999) showed exaggerated
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Figure 3. Clock regulates IL-23 receptor (IL-23R) expression in γ/δ T cells. (a) IL-23 receptor (IL-23R) mRNA expression in splenic γ/δ+ T cells isolated
from wild-type mice or ClockΔ19/Δ19 mice (n= 3 per group). (b) Frequency of splenic γ/δ+IL-23R+ cells isolated from wild-type mice or ClockΔ19/Δ19 mice (n= 4
per group). (c) Detection of CLOCK binding to the promoter region of IL-23R in splenic γ/δ+ T cells isolated from wild-type mice evaluated by chromatin
immunoprecipitation (ChIP) assay. The values represent means± SD. *Po0.05.
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Figure 2. Clock mutation blunts γ/δ+ T cell responses to IL-23.
(a) IL-23-induced IL-22 and IL-17A production in splenic γ/δ+ T cells isolated
from wild-type or ClockΔ19/Δ19 mice detected by ELISA (n=3 per group).
(b and c) Wild-type or ClockΔ19/Δ19 mice underwent intradermal injection
of phosphate-buffered saline (PBS) or IL-23 in the ears on days 1, 3, and 5 at
Zeitgeber time 2 (ZT2). (b) Ear thickness (n= 4–5 per group) or (c) hematoxylin
and eosin (HE) staining of the ear and its quantitative analysis (epidermal
thickness) (n=4–5 per group) on day 6 are shown. Bar=100 μm. The values
represent means± SD. *Po0.05.
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IMQ-induced dermatitis compared with wild-type mice, as
judged by the PASI score in the dorsal skin, ear thickness, and
frequency of CD3+ γ/δ+ T cells in the cervical lymph nodes
(Figure 5a–c). Frequency of γ/δ+ IL-22+ cells or CD3+IL-22+
cells in the cervical lymph nodes also increased in IMQ-
treated mPer2m/m mice compared with IMQ-treated wild-type
mice (Figure 5c). In basal conditions, mPer2m/m mice showed
increased IL-23R mRNA and protein expression in splenic
γ/δ+ T cells compared with wild-type mice (Figure 5d and e).
Consistently, direct treatment of mPer2m/m mice with mouse
recombinant IL-23 also induced signiﬁcantly severe levels of
dermatitis compared with wild-type mice, as judged by ear
thickness and epidermal hyperplasia (Figure 5f and g). These
ﬁndings suggested that Per2 mutation exaggerated IMQ-
induced dermatitis in mice in contrast to Clock mutation,
which was associated with increased IL-23R and also IL-22
expression.
Mast cells have a marginal role in IMQ-induced dermatitis in the
current experimental conditions
Mast cells have a regulatory role in the development of IMQ-
induced dermatitis in mice—in particular, in the initiation
phase of dermatitis—via regulation of tumor necrosis factor-α
and IL-1β (Heib et al., 2007). In addition, we have previously
shown that Clock mutation affects IgE–mediated mast cell
responses (Nakamura et al., 2011, 2014). Thus, it is possible
that Clock mutation affects mast cell functions, thereby
inﬂuencing IMQ-induced dermatitis.
To determine whether mast cells have a role in IMQ-
induced dermatitis in our experimental conditions, we
compared the development of IMQ-induced dermatitis
between mast cell–deﬁcient W/Wv mice and their control
mice. The extents of IMQ-induced dermatitis were compar-
able between these mice as judged by the PASI score in the
dorsal skin, ear thickness, epidermal thickness, and frequency
of CD3+γ/δ+ T cells in the cervical lymph nodes
(Supplementary Figure S6a and d online). These ﬁndings
suggested that mast cells had a marginal role in IMQ-induced
dermatitis in the current experimental conditions.
DISCUSSION
This study showed that a loss-of-function mutation of the
integral circadian gene Clock ameliorated IMQ-induced
psoriasis-like skin inﬂammation in mice, which was asso-
ciated with decreased IL-23R expression in γ/δ+ T cells.
Consistently, CLOCK directly bound to the promoter of IL-23R
in γ/δ+ T cells, and IL-23R expression in the mouse skin
was under circadian control. In contrast, a loss-of-function
mutation of Per2, another key clock protein that inhibits
CLOCK activity, exaggerated IMQ-induced skin inﬂammation
associated with increased IL-23R expression in γ/δ+ T cells.
Collectively, these ﬁndings suggested that Clock regulated
IMQ-induced psoriasis-like skin inﬂammation in mice partly
via direct modulation of IL-23R expression in γ/δ+ T cells.
Given that IL-23R is a candidate gene involved in the
pathogenesis of psoriasis (Capon et al., 2007), Clock may
have an important regulatory role in psoriasis, which may
provide new insight into previously unknown aspects of the
biology of psoriasis.
We showed that Clock mutation blunted γ/δ+ T cell
responses to IL-23 in vitro: IL-23-induced IL-17A and IL-22
production decreased in Clock-mutated splenic γ/δ+ T cells
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(Figure 2a) associated with reduced IL-23R expression (Figure
3a and b). However, in contrast to IL-22 expression,
expression levels of skin IL-17A mRNA and frequency of
γ/δ+ IL-17A+ cells in the cervical lymph nodes were compa-
rable between IMQ-treated wild-type mice and ClockΔ19/Δ19
mice (Figure 1e and Supplementary Figure S4 online). IL-17A
was produced not only by γ/δ+ T cells but also by T helper
type 17 cells and type 3 innate lymphoid cells (ILC3) (Artis
and Spits, 2015). ILC3 has been recently suggested to have a
critical role in human psoriasis by producing IL-17A produc-
tion via IL-23R signaling (Ward and Umetsu, 2014). So far, the
relative contribution of γ/δ+ T cells, T helper type 17 cells, or
ILC3 to IL-17A production in the IMQ-treated mouse skin
remains unclear. Thus, given that CD3+ IL-17A+ cells in the
cervical lymph nodes were comparable between wild-type
and ClockΔ19/Δ19 mice (Supplementary Figure S4 online), the
comparable IL-17A mRNA and protein expression in the skin
between wild-type and ClockΔ19/Δ19 mice could be attributed
to IL-17A production by ILC3. In this case, Clock might
regulate IL-23R expression selectively in γ/δ+ T cells, but not
in ILC3, because it is well accepted that Clock-controlled
genes are regulated in a cell-type– or tissue-speciﬁc manner
(Partch et al., 2014). We would like to address this issue in
future studies because it would be beyond the current scope
to determine whether Clock regulated induction or activation
of ILC3 in general or under particular conditions such as IMQ-
induced skin pathology.
The ﬁndings that Clock mutation decreased IL-23R expres-
sion and CLOCK directly bound to the E-box-like elements in
the promoter region of IL-23R in γ/δ+ T cells suggested that
IL-23R was a direct target gene by CLOCK. As PER2 inhibits
CLOCK activity, it was most likely that Per2 mutation failed to
inhibit CLOCK activity, leading to increased IL-23R expres-
sion in γ/δ+ T cells. The opposite severity observed in
IMQ-treated Clock- or Per2–mutated mice compared with
wild-type mice also supported this notion.
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Figure 5. Period2 (Per2) mutation enhances imiquimod (IMQ)-induced skin inﬂammation. (a) Psoriasis Area Severity Index (PASI) score in the dorsal skin
(n= 3–4 per group). (b) Ear thickness (n= 3–4 per group). (c) Frequency of γ/δ T cells (CD3+γ/δ+, IL-22+γ/δ+s, and CD3+IL-22+ cells) in the cervical lymph nodes
evaluated by FACS analysis on day 6 (n= 3 per group). (d) IL-23 receptor (IL-23R) mRNA expression evaluated by quantitative reverse transcriptase in real time
(qPCR) in splenic γ/δ+ T cells isolated from nontreated wild-type mice ormPer2m/mmice (n=3 per group). (e) Frequency in splenic γ/δ+IL-23R+ cells isolated from
nontreated wild-type or mPer2m/m mice evaluated by FACS analysis at Zeitgeber time 2 (ZT2) (n= 3 per group). (f and g) Wild-type mice or mPer2m/m mice
underwent intradermal injection of phosphate-buffered saline (PBS) or IL-23 in the ears on days 1, 3, 5, 7, and 9 at ZT2. (f) Ear thickness (n= 3 per group) or (g)
hematoxyin and eosin (HE) staining of the ear and its quantitative analysis (epidermal thickness) (n=3 per group) on day 10 are shown. Bar=100 μm. The values
represent the means± SD. *Po0.05.
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IMQ-induced dermatitis exhibited a time-of-day-dependent
variation in wild-type mice, possibly in association with
circadian IL-23R expression in the skin (Figure 4). However, it
remains to be determined whether the circadian variation of
IL-23R expression in the skin really determines the optical
timings or outcomes of daily treatment with IMQ for the
generation of skin lesions, as the ﬂuctuation of mIL-23R
appeared to be little.
Of note, we used mice with an ICR background for Per2
mutation experiments (Figure 5) as we failed to have enough
numbers of Per2–mutated mice for experiments because of
poor fertility of Per2–mutated mice with a C57BL/6 back-
ground. The different genetic backgrounds might lead to
different sensitivity levels to IMQ treatment (e.g., PASI scoring,
ear thickness) in mice. It appeared that ICR mice exhibited
less IMQ- or IL-23-induced dermatitis compared with
C57BL/6 mice, as judged by the PASI score in the dorsal
skin, ear thickness, and epidermal hyperplasia. In addition,
ClockΔ19/Δ19 mice exhibited signiﬁcantly reduced ear thick-
ness on day 2 compared with wild-type mice (Figure 1b),
which was not observed in mPer2m/m mice (Supplementary
Figure S5b online). It is possible that this early reduction of ear
thickness (dermal edema) in ClockΔ19/Δ19 mice might be
caused by intrinsic effects of Clock mutation on the skin, such
as anomaly, but not by IMQ treatment.
In the current experimental conditions, mast cell deﬁciency
did not affect IMQ-induced skin inﬂammation in mice
(Supplementary Figure S6 online). A previous study reported
that mast cells were essential to initiate an early inﬂammatory
reaction in IMQ-induced dermatitis in mice via regulation of
tumor necrosis factor-α and IL-1β (Heib et al., 2007). Different
experimental conditions such as the concentration of topical
IMQ (2.5% in the current study vs. 5% in the others study)
and possible skin microbe variations in mice housed in
different facilities (Zeeuwen et al., 2013) might explain the
discrepancy, although the precise reasons remain unclear.
We have previously shown that ClockΔ19/Δ19 mice exhibit
signiﬁcantly severe levels of allergic contact dermatitis
compared with wild-type mice, where the mice were treated
with TNCB (2,4,6-trinitro-1-chlorobenzene) on the abdominal
skin on day 0 (sensitization) and then with TNCB on the ears
on day 5 (challenge) (Takita et al., 2013). The exaggerated
allergic contact dermatitis phenotypes in ClockΔ19/Δ19 mice
were associated with increased Th2-type responses such as
serum IgE levels and mast cell number in the skin. Therefore,
it appears that Clock mutation affects the development of
IMQ-induced skin inﬂammation and allergic contact derma-
titis in mice differently, possibly because of different
inﬂuences of Clock mutation on their pathophysiology.
There have been several reports suggesting that psoriasis
may be linked to aberrant circadian rhythms. Importantly, a
most recent study suggested an increased risk for psoriasis in
night-shift workers who had aberrant circadian rhythms
(Li et al., 2013). Our ﬁndings in mice implicate that Clock
may be a potent regulator of psoriasis by affecting IL-23R
expression. Thus, we speculate that aberrant circadian
rhythms affecting Clock expression or activity might enhance
susceptibility to psoriasis by increasing IL-23R expression or
by other unknown mechanisms. More human studies are
therefore clearly needed to determine how strongly the
circadian clock (or its disruption) inﬂuences the predisposi-
tion, etiology, maintenance, and progression of psoriasis.
In summary, we propose that Clock is a novel regulator of
psoriasis-like skin inﬂammation in mice. To the best of our
knowledge, this is the ﬁrst study to reveal a mechanistic link
between psoriasis and the circadian clock, which will provide
a novel insight into the pathophysiology of psoriasis.
MATERIALS AND METHODS
Mice
Female C57BL/6 ClockΔ19/Δ19 mice, their wild-type littermates, ICR
Per2–mutated mice (mPer2m/m mice) (Zheng et al., 1999), and
control ICR mice were bred under speciﬁc pathogen-free conditions.
All mice were housed under 12-hour light/12-hour dark conditions
(light/dark (L/D) 12:12 cycles; the light was turned on at 0600 hours,
ZT0, and the light was turned off at 0600 hours, ZT12) with ad
libitum access to food and water for at least 2 weeks. All animal
experiments were approved by the Institutional Review Board of the
University of Yamanashi.
IMQ-induced psoriasis-like skin inﬂammation
Mice were treated daily for 5 consecutive days on both ears and on
the shaved dorsal skin with 31.2 mg of commercially available IMQ
cream (5% Beselna cream; Mochida Pharmaceutical, Tokyo, Japan)
or Vaseline at ZT2. IMQ cream was mixed with Vaseline in a 1:1
ratio and used.
Intradermal IL-23 injection
To induce IL-23-mediated psoriasis-like skin inﬂammation, 20 μl
phosphate-buffered saline, either alone or containing 500 ng
recombinant mouse IL-23 (BioLegend, San Diego, CA), was
intradermally injected into the ears of anesthetized mice using a
30-gauge needle, under a microscope (Wraymer, Osaka, Japan)
at ZT2.
Scoring severity of skin inﬂammation
Ear thickness was measured using an engineer’s micrometer at
indicated time points. The Δ ear thickness is calculated as the
changes in ear thickness ((ear thickness at the indicated time
points)− (ear thickness before treatment on day 0)). A scoring system
based on the clinical Psoriasis Area and Severity Index was used (van
der Fits et al., 2009).
Splenic γ/δ+ T cell preparation and culture
γ/δ+ T cells were puriﬁed from spleens using a mouse γ/δ+ TCR+ T
cell Isolation Kit (Milteny Biotec, Bergisch Gladbach, Germany) at
ZT2. Cells were stimulated for 72 hours with IL-23 (10 ngml−1; R&D,
Minneapolis, MN) or medium alone in the presence of anti-CD3
(2 μgml− 1; eBioscience, San Diego, CA). After 72 hours, IL-17A or
IL-22 concentrations in the supernatants were determined by ELISA
(eBioscience).
Chromatin immunoprecipitation assay
Chromatin Immunoprecipitation assay was performed as described
previously (Nakamura et al., 2014).
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Statistical analysis
The statistical analyses were performed using the unpaired Student's
t-test for two-group comparisons, and analysis of variance for
comparison between more than two groups.
For more information, see the Supplementary Methods section in
this article’s Online Repository.
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